Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Condition(s):Dyslipidemias; Atherosclerosis; Diabetes Mellitus, Type 2Last Updated:October 4, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Dyslipidemias; Atherosclerosis; Diabetes Mellitus, Type 2Last Updated:October 4, 2022Recruiting
Condition(s):HealthyLast Updated:March 3, 2014Completed
Condition(s):HealthyLast Updated:September 20, 2018Completed
Condition(s):Schizophrenia ProdromeLast Updated:May 22, 2014Completed
Condition(s):Liver Metastasis; Colon CancerLast Updated:December 6, 2023Active, not recruiting
Condition(s):Colon Cancer Liver MetastasisLast Updated:November 28, 2023Recruiting
Condition(s):Depressive Disorder; DepressionLast Updated:January 17, 2008Completed
Condition(s):Lipid Disorder; Triglycerides High; DyslipidemiasLast Updated:November 11, 2021Completed
Condition(s):Healthy VolunteersLast Updated:December 14, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.